Growth Metrics

Biofrontera (BFRI) Cash from Investing Activities (2021 - 2025)

Biofrontera has reported Cash from Investing Activities over the past 5 years, most recently at $3.0 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 300200.0% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $3.0 million, up 560.35%, while the annual FY2025 figure was $3.0 million, 100033.33% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $3.0 million at Biofrontera, up from $1000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $3.0 million in Q4 2025 and troughed at -$3.0 million in Q3 2022.
  • A 5-year average of -$103200.0 and a median of -$1000.0 in 2024 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 303500.0% in 2022 and later skyrocketed 300200.0% in 2025.
  • Year by year, Cash from Investing Activities stood at -$9000.0 in 2021, then crashed by 23077.78% to -$2.1 million in 2022, then surged by 103.5% to $73000.0 in 2023, then crashed by 101.37% to -$1000.0 in 2024, then skyrocketed by 300200.0% to $3.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for BFRI at $3.0 million in Q4 2025, $1000.0 in Q3 2025, and -$1000.0 in Q2 2025.